152 related articles for article (PubMed ID: 19625274)
1. Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.
Saratzis A; Kitas GD; Saratzis N; Melas N
Angiology; 2010 Feb; 61(2):137-44. PubMed ID: 19625274
[TBL] [Abstract][Full Text] [Related]
2. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
[TBL] [Abstract][Full Text] [Related]
3. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.
Sukhija R; Aronow WS; Sandhu R; Kakar P; Babu S
Am J Cardiol; 2006 Jan; 97(2):279-80. PubMed ID: 16442379
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin suppresses experimental aortic aneurysm expansion.
Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
[TBL] [Abstract][Full Text] [Related]
6. Toward a role for statins in immunomodulation.
Mach F
Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
[TBL] [Abstract][Full Text] [Related]
7. Statins enhance circulating vitamin E.
Cangemi R; Loffredo L; Carnevale R; Pignatelli P; Violi F
Int J Cardiol; 2008 Jan; 123(2):172-4. PubMed ID: 17306387
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
Neuhaus O; Hartung HP
Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.
Shiraya S; Miyake T; Aoki M; Yoshikazu F; Ohgi S; Nishimura M; Ogihara T; Morishita R
Atherosclerosis; 2009 Jan; 202(1):34-40. PubMed ID: 18482727
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Chalifour LE
Can J Physiol Pharmacol; 2009 Nov; 87(11):915-22. PubMed ID: 19935899
[TBL] [Abstract][Full Text] [Related]
12. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Cardiovasc Res; ; . PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]